Pierre Villeneuve

Research

Read how they describe their research on their University of Ottawa profile.

Latest funding

Low-dose direct oral anticoagulant compared to aspirin for the thromboprophylaxis of patients with JAK2-positive myeloproliferative neoplasms
CIHR · 2024 · Co-investigator
$1,350,226

All 1 grants and awards

No publications available.

Low-dose direct oral anticoagulant compared to aspirin for the thromboprophylaxis of patients with JAK2-positive myeloproliferative neoplasms

Co-investigatorCIHR2024Project Grant

Principal investigators: Kimpton, Miriam; Delluc, Aurelien

Keywords: Cancer; Cardiovascular Outcomes; Randomized Controlled Trial; Thrombosis

$1,350,226

From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.

Write to this professor

A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.

Applying for

Subject: Prospective PhD student Dear Professor Villeneuve, My name is [your name], and I am a [your current degree or role] at [your institution]. I am applying for a PhD position starting in [term and year]. Your research connects closely to my own work on [your research topic]. [One or two sentences on what you did and what you learned.] Are you accepting new PhD students for [term and year]? I have attached my CV and transcripts, and I would be glad to talk at a time that suits you. Thank you for your time. Kind regards, [your name]